Tag: vaccine

Major European nations suspend use of AstraZeneca vaccine

Germany, France and Italy on Monday became the latest countries to suspend use of AstraZeneca’s COVID-19 vaccine over reports of dangerous blood clots in some recipients, though the company and European regulators have said there is no evidence the shot is to blame. AstraZeneca’s formula is just one of three vaccines in use on the

AstraZeneca vaccine not to blame for Austria death: EMA

Europe’s medicines watchdog said Wednesday a preliminary probe showed that a batch of AstraZeneca vaccines used in Austria was likely not to blame for the death of a nurse who received a jab. Austria on Monday announced it would stop using doses from the batch, made by the British-Swedish firm with Oxford University, after the

California to give 40% of vaccine doses to vulnerable areas

California will begin setting aside 40% of all vaccine doses for the state’s most vulnerable neighborhoods in an effort to inoculate people most at risk from the coronavirus and get the state’s economy open more quickly. Two officials in Gov. Gavin Newsom’s administration shared details Wednesday on condition of anonymity. The doses will be spread

Fauci Says US Must Stick to Two-Shot Strategy for COVID Vaccines

(Reuters) – The United States must stick to a two-dose strategy for the Pfizer-BioNTech and Moderna COVID-19 vaccines, top U.S. infectious disease official Anthony Fauci told the Washington Post newspaper. Fauci said that delaying a second dose to inoculate more Americans creates risks. He warned that shifting to a single-dose strategy for the vaccines could

EU Considers Switch to COVID-19 Vaccine Emergency Approvals

BRUSSELS (Reuters) – The European Commission said on Tuesday that it was considering emergency approvals for COVID-19 vaccines as a faster alternative to more rigorous conditional marketing authorisations which have been used so far. The move would mark a big shift in approach to vaccine approvals, as it would entail using a procedure that the

Nanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies

Researchers from Cleveland Clinic’s Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models. According to new findings published in mBio, the vaccine produced potent neutralizing antibodies among preclinical models and also prevented infection and disease symptoms

Ethnic minorities have less access to COVID-19 vaccines, finds study

With several vaccines already having received Emergency Use Authorization (EUA) against coronavirus disease 2019 (COVID-19), vaccination campaigns have already begun in several countries the world over. However, as with the disease itself, the remedy continues to be plagued by issues of inequity and disparity. A new preprint examines the racial and ethnic differences between COVID-19

Spain: One Vaccine Dose to Under 55-Year-Olds Who Had COVID

MADRID (Reuters) – Spain will give a single vaccine dose to under 55-year-olds who have already been infected with COVID-19, the Health Ministry announced on Friday in the latest update of its national inoculation strategy. “The duration of protective immunity to the virus after natural infection is unknown but studies show that administering a single

White House: COVID-19 Numbers Take a ‘Concerning Shift’

Feb. 26, 2021 — After several weeks of declining, COVID-19 numbers are back on the rise and new variants continue to emerge, according to White House officials — just as states begin to lift restrictions and open doors to restaurants and businesses. CDC Director Rochelle Walensky, MD, reported during a Friday COVID-19 briefing that coronavirus cases and

Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission

New data from Addenbrooke’s Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by four-fold the number of asymptomatic SARS-CoV-2 infections. This implies that the vaccine could significantly reduce the risk of transmission of the virus from people who are asymptomatic, as well as protecting others from getting ill.

Vietnam says panel recommends Sputnik V, Moderna vaccines for use

HANOI/MOSCOW (Reuters) – Vietnam plans to acquire 150 million doses for its COVID-19 vaccination programme, as the health ministry said a medical panel had recommended it approve Russia’s Sputnik V vaccine and the Moderna vaccine for use in the Southeast Asian country. The 150 million doses will include both those directly purchased and doses obtained

EU Mulls Vaccination Passports to Resurrect Tourism After COVID-19

BRUSSELS (Reuters) – European Union leaders will agree on Thursday to work on certificates of vaccination for EU citizens who have had an anti-COVID shot, with southern EU countries that depend heavily on tourism desperate to rescue this summer’s holiday season. Lockdowns to slow the pandemic caused the deepest ever economic recession in the 27-nation

Sweden to Ease COVID Rules for Vaccinated Care Home Residents

STOCKHOLM (Reuters) – Sweden will ease restrictions on elderly residents of care homes who have been vaccinated against COVID-19, the country’s top epidemiologist said on Wednesday, at the same time as rules for the rest of the country are tightened. Sweden has seen a rise in cases in the last couple of weeks, raising fears

China approves two COVID-19 vaccines from Sinopharm's affiliate, CanSino

FILE PHOTO: A logo of China’s vaccine specialist CanSino Biologics Inc is pictured in Tianjin, China August 17, 2020. REUTERS/Thomas PeterBEIJING (Reuters) – China’s National Medical Products Administration said on Thursday that it has approved two more COVID-19 vaccines for public use. The two vaccines are made by CanSino Biologics Inc and Sinopharm’s affiliate Wuhan